Literature DB >> 6733694

In vitro binding of amantadine to plasma proteins.

P Liu, P J Cheng, T S Ing, J T Daugirdas, R Jeevanandhan, L S Soung, S Galinis.   

Abstract

In vitro binding of amantadine to plasma protein was assessed by ultrafiltration of plasma samples (from a blood bank) to which amantadine hydrochloride had been added. Approximately two-thirds of the amantadine was found to be protein-bound. The degree of protein binding was constant over a plasma amantadine concentration range of 100-2,000 ng/ml.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733694     DOI: 10.1097/00002826-198406000-00005

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  4 in total

Review 1.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  Cardiotoxicity after massive amantadine overdose.

Authors:  Michael Schwartz; Manish Patel; Ziad Kazzi; Brent Morgan
Journal:  J Med Toxicol       Date:  2008-09

Review 3.  Clinical pharmacokinetics of amantadine hydrochloride.

Authors:  F Y Aoki; D S Sitar
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

4.  Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets.

Authors:  Tina deVries; Angela Dentiste; Clifford Di Lea; Vincent Pichette; David Jacobs
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.